These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32558608)
1. Challenges in the management of localized Ewing sarcoma in a developing country. Totadri S; Bansal D; Rao KLN; Jain R; Saxena AK; Kapoor R; Samujh R; Trehan A Pediatr Hematol Oncol; 2020 Oct; 37(7):610-619. PubMed ID: 32558608 [TBL] [Abstract][Full Text] [Related]
2. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ; Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. Womer RB; West DC; Krailo MD; Dickman PS; Pawel BR; Grier HE; Marcus K; Sailer S; Healey JH; Dormans JP; Weiss AR J Clin Oncol; 2012 Nov; 30(33):4148-54. PubMed ID: 23091096 [TBL] [Abstract][Full Text] [Related]
4. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313 [TBL] [Abstract][Full Text] [Related]
5. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
6. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014 [TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
8. Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study. Ferrari S; Palmerini E; Alberghini M; Staals E; Mercuri M; Barbieri E; Longhi A; Cantero L; Cesari M; Abate M; Balladelli A; Picci P; Bacci G Tumori; 2010; 96(2):213-8. PubMed ID: 20572576 [TBL] [Abstract][Full Text] [Related]
9. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience. Zhang J; Huang Y; Sun Y; He A; Zhou Y; Hu H; Yao Y; Shen Z BMC Cancer; 2019 Dec; 19(1):1168. PubMed ID: 31791278 [TBL] [Abstract][Full Text] [Related]
10. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153 [TBL] [Abstract][Full Text] [Related]
11. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
13. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol. Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999 [TBL] [Abstract][Full Text] [Related]
14. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. Granowetter L; Womer R; Devidas M; Krailo M; Wang C; Bernstein M; Marina N; Leavey P; Gebhardt M; Healey J; Shamberger RC; Goorin A; Miser J; Meyer J; Arndt CA; Sailer S; Marcus K; Perlman E; Dickman P; Grier HE J Clin Oncol; 2009 May; 27(15):2536-41. PubMed ID: 19349548 [TBL] [Abstract][Full Text] [Related]
15. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ; J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035 [TBL] [Abstract][Full Text] [Related]
16. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966 [TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04. Chin M; Yokoyama R; Sumi M; Okita H; Kawai A; Hosono A; Koga Y; Sano H; Watanabe H; Ozaki T; Mugishima H; Pediatr Blood Cancer; 2020 May; 67(5):e28194. PubMed ID: 32077253 [TBL] [Abstract][Full Text] [Related]
18. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741 [TBL] [Abstract][Full Text] [Related]